Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

Inclusion criteria: * Documented HIV-1 infection with screening viral load between 5000 and 300,000 copies/mL. * Baseline CD4 cell count greater than 100. * Females must be of non-childbearing potential * Not have received antiretroviral therapy in the 12 weeks prior to first dose. Exclusion criteria: * Must not be infected with hepatitis B or C. * Patients must not have any acute laboratory abnormality. * Must not have any active CDC (Centers for Disease Control and Prevention)Category C disease (1993), except cutaneous Kaposi's sarcoma not requiring systemic therapy during the trial.